|
|
Post by centralcoastinvestor on Dec 15, 2016 9:25:30 GMT -5
Wouldn't it be ironic if MannKind became the leading company for hiring sales reps for diabetes in the years ahead. As Sanofi, Novo and Lilly drop people, Mnkd hires. I like the sound of that.
|
|
|
|
Post by promann on Dec 15, 2016 9:28:49 GMT -5
Ha Ha Ha You people are something else.. Yes they are trying to sell Afrezza but they have not gone full bore yet not even close.. You just wait.. Better insurance coverage better labeling and the TV commercials and the awareness with the testimonials will kick in and the Blockbuster.. I dont care what you naysayers say MNKD has just begun to try to sell Afrezza
|
|
|
|
Post by sophie on Dec 15, 2016 14:11:03 GMT -5
To be honest I dont think MNKD has even tried to sell Afrezza yet.. I know I know we said the same thing with Sanofi.. But the reasoning still remains.. Better insurance coverage, better labeling, more first user testimonials.. I think we are getting everything in place for a major awareness and marketing campaign coming in the next couple months... Everyone hold tight and fasten your seat belts for lift off. Not selling one share until SP hits all time highs. So management has been lying to us for two years about the sales and marketing attempts and they are basically sitting around at their office watching youtube cat videos until insurance coverage and labeling improves? And you're still using the "awareness" card after all these months? That card expired over a year ago! |
|
|
|
Post by promann on Dec 15, 2016 14:42:57 GMT -5
So management has been lying to us for two years about the sales and marketing attempts and they are basically sitting around at their office watching youtube cat videos until insurance coverage and labeling improves? And you're still using the "awareness" card after all these months? That card expired over a year ago! |
|
|
|
Post by sportsrancho on Dec 15, 2016 14:56:27 GMT -5
And you're still using the "awareness" card after all these months? That card expired over a year ago!
There is a awareness problem! Most diabetics are only aware of the new drugs they see on TV unless their doctors tell them. Most do not go on walks or post on message boards. That's why there is so much up-side coming:-) Also once a celebrity gets on TV talking about Afrezza...that's the tipping point IMO.
|
|
|
|
Post by cjm18 on Dec 15, 2016 15:04:29 GMT -5
The same people on this board complaining that the current sales force is inadequate, unqualified, and understaffed also disagree with the idea that mnkd has not gone full throttle on trying to sell afrezza. That's the epitome of bias and a naysayer. I love reading bearish opinions when they involve logic, reasoning, and facts. I don't like hearing nagging or fact bending.
|
|
|
|
Post by sportsrancho on Dec 15, 2016 15:45:24 GMT -5
Until you hear about something you can't really Google it.
Years ago my girl friends husband stopped smoking and was using e-cigs. I'd never heard of them.
I googled them and read about some e-cigs stocks. GreenSmoke seemed like the best but wasn't public. They didn't look like they were going anywhere. I bought one anyway.
Then a women celebrity smoked a Njoy on a late night talk show and the stocks went crazy. And then big tobacco bought up Blue and Njoy and the rest in history.
There were a lot of little e-cig stocks. There's only one Afrezza:-). ( Just talking about what makes something go viral.) Not comparing.
|
|
|
|
Post by ilovekauai on Dec 15, 2016 16:14:52 GMT -5
I really like what you posted here Proman. Good job and in complete agreement with you. Aloha.
|
|
|
|
Post by Cowgirl on Dec 15, 2016 17:46:24 GMT -5
Problem with reps from Novo or Sanofi etc. is the question "are they passionate about Afrezza" or just passionate about getting a new job? Seems a bit odd that if you were pounding the table about X and Y over the years to a Doc that you then naturally are all "gung ho" Afrezza. Doesn't that come across as kind of lame? Does the Doc really take you seriously when you flip flop in front of his/her face?
And then you got the attitude issue - i.e. "I know all the docs - they love me"...and then nothing materialzes. Look at what happen on Launch 2.0 - we got all these Touchpoint reps, supposedly experienced and well embedded and they can't seem to turn on the faucet on Afrezza sales. New blood is needed as old blood didn't work in 2.0 and most likely won't in what is being called 3.0.
|
|
|
|
Post by letitride on Dec 15, 2016 20:44:27 GMT -5
From everything I have read and heard to date in my opinion the best sales reps for afrezza would be 2 type 1 PWD and CGMs taking doctors out to dinner and a show. One on the pump and the other with afrezza and let the truth be known.
|
|
|
|
Post by brotherm1 on Dec 15, 2016 21:15:12 GMT -5
Wow - How did such a simple idea become so seemingly elusive? That's brilliant. Or perhaps I'm simple and it's already being done?
|
|
|
|
Post by sportsrancho on Dec 15, 2016 21:57:31 GMT -5
The best sales reps for afrezza would be T1 & T2 PWD and CGMs taking doctors out to dinner and a show. One on the pump and the other with afrezza and let the truth be known. letitride Let me know if you want me to tweet this out:-). sports
|
|
|
|
Post by saxcmann on Dec 15, 2016 22:10:58 GMT -5
Problem with reps from Novo or Sanofi etc. is the question "are they passionate about Afrezza" or just passionate about getting a new job? Seems a bit odd that if you were pounding the table about X and Y over the years to a Doc that you then naturally are all "gung ho" Afrezza. Doesn't that come across as kind of lame? Does the Doc really take you seriously when you flip flop in front of his/her face? And then you got the attitude issue - i.e. "I know all the docs - they love me"...and then nothing materialzes. Look at what happen on Launch 2.0 - we got all these Touchpoint reps, supposedly experienced and well embedded and they can't seem to turn on the faucet on Afrezza sales. New blood is needed as old blood didn't work in 2.0 and most likely won't in what is being called 3.0. Agree 100%! They want pharma reps or Mannkind reps? I'll take passion and dedication anytime! |
|
|
|
Post by art606a on Dec 15, 2016 23:44:48 GMT -5
I'm inclined to believe that sales reps are essentially immaterial. This was Mr. Castgna's point about ignoring places like Boston where 50% or more of the endos are employed by managed care companies and it's the managed care companies that essentially decide what the endo can or cannot prescribe. Taking time to see them is useless if the drug is isn't at least tier 2. As for the rest, script numbers tell the tale. They declined steadily throughout the year to a nadir and the 40 new reps, even if they're not the best reps or particularly excited about selling it, simply haven't had much impact. And if you think about it, what can any rep but say here's an inhalable form of insulin that is rapid in/out, and here's some samples. There's not a lot to work with there.
|
|
|
|
Post by falconquest on Dec 16, 2016 5:59:35 GMT -5
I may be shifting my opinion on the idea of using Reps. to "push" Afrezza when perhaps the idea of "pulling" it through the system may work better. If patients are aware, begin demanding it and doctors hear it over and over again then they will have no choice but to learn more and accept the "new" insulin. I'm still on the fence but unless the sales folks start generating real sales, I would go right to the public with it and in a big way. I don't know the source of the revenue that would be required to do it but if you keep running the ball and you're not gaining any yardage at some point you have to throw it and in a big way.
|
|
